Adjusted EBITDA was $847 million, against $806 million, and Adjusted EBITDA attributable to PAA was $711 million, against $669 million. Implied distributableCash Flowper common unit was $0.67, against $0.61. Adjusted free cash flow was $458 million, against $303 million.
Total revenues were $545.9 million, against $488.9 million. Diluted loss per share on aGAAPbasis was $1.08, against earnings of $0.19 in the third quarter of 2025.
Total RevPAR increased 10.5% to $394.97. Excluding Andaz Miami Beach, Hotel Adjusted EBITDAreMarginincreased 50 basis points to 26.7%. Adjusted FFO attributable to common stockholders was $37.2 million, against $31.7 million.
Net income from continuing operations was $85 million, against $71 million. Including discontinued operations, net loss was $199 million, againstNet Incomeof $57 million. All figures exclude Europe unless noted, and prior periods were recast.
Net income was $58.715 million, against a net loss of $73.118 million.Diluted Earnings per Shareattributable to TDS common shareholders were $0.25, compared with a loss of $0.84. Diluted earnings per share from continuing operations were $0.26, against $0.33, and the loss per share from …
Operating loss was $88.2 million, compared with $24.7 million a year earlier, and non-GAAP Adjusted EBITDA was approximately negative $12.8 million.Net Incomeattributable to the company was $709.9 million. The statements show a $728.4 million gain from the change in fair value ofWarrantand derivative liabilities, …
The company attributed the decline mainly to a shift in revenue mix toward lower-priced, minimally invasive products and a lowerVolumeof bunion procedure kits sold. Excluding sales to stocking distributors, bunion kit sales volume increased and revenue grew at a mid single-digit rate compared with …
Net sales decreased by $94.3 million, or 7.2%, to $1.2 billion. The company said apparel decreased primarily because of lower unit sales. License revenues were $27.8 million, down 4.1% from $29.0 million.
Net loss was $32.1 million, against $20.2 million. After net loss attributable to noncontrolling interest of $7.8 million, diluted loss per share was $0.27, compared with $0.17.
Operating revenues were $6.347 billion, compared with $4.971 billion in the same quarter of 2025. The company said net income rose by $488 million, driven primarily by higher EBITDA and an increase of $375 million in unrealized mark-to-market gains on derivative positions. It said …